1. Home
  2. PFAI vs LSTA Comparison

PFAI vs LSTA Comparison

Compare PFAI & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFAI
  • LSTA
  • Stock Information
  • Founded
  • PFAI 2015
  • LSTA 1980
  • Country
  • PFAI Canada
  • LSTA United States
  • Employees
  • PFAI N/A
  • LSTA N/A
  • Industry
  • PFAI Farming/Seeds/Milling
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • PFAI Consumer Staples
  • LSTA Health Care
  • Exchange
  • PFAI Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • PFAI 21.1M
  • LSTA 22.3M
  • IPO Year
  • PFAI 2025
  • LSTA N/A
  • Fundamental
  • Price
  • PFAI $2.60
  • LSTA $2.17
  • Analyst Decision
  • PFAI
  • LSTA Strong Buy
  • Analyst Count
  • PFAI 0
  • LSTA 2
  • Target Price
  • PFAI N/A
  • LSTA $23.50
  • AVG Volume (30 Days)
  • PFAI 267.4K
  • LSTA 25.5K
  • Earning Date
  • PFAI 01-01-0001
  • LSTA 08-07-2025
  • Dividend Yield
  • PFAI N/A
  • LSTA N/A
  • EPS Growth
  • PFAI N/A
  • LSTA N/A
  • EPS
  • PFAI 0.03
  • LSTA N/A
  • Revenue
  • PFAI $3,289,862.00
  • LSTA $1,070,000.00
  • Revenue This Year
  • PFAI N/A
  • LSTA N/A
  • Revenue Next Year
  • PFAI N/A
  • LSTA N/A
  • P/E Ratio
  • PFAI $87.13
  • LSTA N/A
  • Revenue Growth
  • PFAI 56.60
  • LSTA N/A
  • 52 Week Low
  • PFAI $1.30
  • LSTA $1.87
  • 52 Week High
  • PFAI $4.40
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • PFAI N/A
  • LSTA 37.46
  • Support Level
  • PFAI N/A
  • LSTA $2.55
  • Resistance Level
  • PFAI N/A
  • LSTA $2.63
  • Average True Range (ATR)
  • PFAI 0.00
  • LSTA 0.17
  • MACD
  • PFAI 0.00
  • LSTA -0.04
  • Stochastic Oscillator
  • PFAI 0.00
  • LSTA 17.86

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: